The pharma firm added that ILUMYA has received marketing authorisation from more than 55 health authorities worldwide since its original approval, including in India, Japan, the European Union, China, Australia and Canada.
The pharma firm added that ILUMYA has received marketing authorisation from more than 55 health authorities worldwide since its original approval, including in India, Japan, the European Union, China, Australia and Canada.